Foot Ulcer Trials Unit, Department of Diabetes and Endocrinology, Nottingham University Hospitals Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.
Diabetologia. 2017 Dec;60(12):2337-2340. doi: 10.1007/s00125-017-4429-6. Epub 2017 Sep 21.
In a paper in this issue of Diabetologia (DOI: https://doi.org/10.1007/s00125-017-4417-x ), Vouillarmet and colleagues have explored the use of single-photon emission computed tomography (SPECT)/computed tomography (CT) to define remission during non-surgical management of osteomyelitis of the foot. Their experience in a non-controlled observational study of 45 individuals was that a negative white blood cell-SPECT/CT scan is a reliable marker of remission, while a positive scan at the end of antibiotic treatment may be relatively useful in the prediction of future short- to medium-term relapse. These findings and conclusions are discussed in the light of current uncertainties relating to the diagnosis of bone infection and the lack of any tested measure that can be used to indicate either its presence or its persistence. In this respect, it is concluded that the value of this approach, and in which population, remains to be clearly established.
在本期《糖尿病学》杂志上的一篇论文中(DOI:https://doi.org/10.1007/s00125-017-4417-x),Vouillarmet 及其同事探讨了在足部骨髓炎的非手术治疗期间使用单光子发射计算机断层扫描(SPECT)/计算机断层扫描(CT)来定义缓解的情况。他们在一项针对 45 名个体的非对照观察性研究中的经验是,阴性白细胞 SPECT/CT 扫描是缓解的可靠标志物,而在抗生素治疗结束时的阳性扫描可能在预测未来的短期至中期复发方面相对有用。这些发现和结论是在与骨感染的诊断相关的现有不确定性以及缺乏可用于指示其存在或持续存在的任何经过测试的措施的背景下进行讨论的。在这方面,得出的结论是,这种方法的价值以及在哪些人群中仍然需要明确确定。